Hyperion DeFi (NASDAQ:HYPD) Releases Earnings Results

Hyperion DeFi (NASDAQ:HYPD) issued its quarterly earnings results on Wednesday. The company reported $0.92 earnings per share for the quarter, Zacks reports.

Hyperion DeFi Stock Performance

Hyperion DeFi stock traded up $0.05 during trading hours on Wednesday, hitting $2.69. 121,860 shares of the stock traded hands, compared to its average volume of 436,417. The firm’s 50 day moving average price is $2.94 and its 200-day moving average price is $3.36. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.97 and a quick ratio of 1.97. The stock has a market capitalization of $40.78 million, a price-to-earnings ratio of -0.27 and a beta of 2.53. Hyperion DeFi has a 1 year low of $2.34 and a 1 year high of $15.00.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on HYPD shares. Cantor Fitzgerald increased their price objective on shares of Hyperion DeFi from $4.00 to $6.60 and gave the company an “overweight” rating in a research report on Wednesday, July 1st. Zacks Research raised shares of Hyperion DeFi from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 14th. Weiss Ratings upgraded shares of Hyperion DeFi from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, June 24th. Finally, Chardan Capital reaffirmed a “buy” rating and issued a $7.30 price target on shares of Hyperion DeFi in a report on Tuesday. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $6.95.

Insider Activity

In other news, insider Hyunsu Jung acquired 7,000 shares of Hyperion DeFi stock in a transaction dated Monday, June 1st. The stock was purchased at an average cost of $3.70 per share, for a total transaction of $25,900.00. Following the completion of the purchase, the insider directly owned 1,384,676 shares in the company, valued at $5,123,301.20. This trade represents a 0.51% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 7.50% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Hyperion DeFi

A number of institutional investors have recently bought and sold shares of the business. Price T Rowe Associates Inc. MD acquired a new stake in Hyperion DeFi during the 4th quarter valued at approximately $73,000. State Street Corp acquired a new stake in shares of Hyperion DeFi in the fourth quarter worth $92,000. Geode Capital Management LLC purchased a new position in shares of Hyperion DeFi during the fourth quarter worth $214,000. Focus Partners Advisor Solutions LLC purchased a new position in shares of Hyperion DeFi during the fourth quarter worth $221,000. Finally, Jane Street Group LLC purchased a new position in shares of Hyperion DeFi during the fourth quarter worth $493,000. 25.84% of the stock is owned by hedge funds and other institutional investors.

Hyperion DeFi Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.